Nivolumab plus ipilimumab combination therapy in cancer: Current evidence to date
Marzieh Nikoo, Fatemeh Rabiee, Hossein Mohebbi, Negar Eghbalifard, Hamid Rajabi, Yalda Yazdani, Delaram Sakhaei, Mohammadreza Khosravifarsani, Reza Akhavan‐Sigari
Topics & Concepts
IpilimumabNivolumabMedicineCombination therapyOncologyCancerImmunotherapyAdverse effectMelanomaInternal medicineClinical trialFood and drug administrationPharmacologyCancer researchCancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmunotherapy and Immune Responses